Key clinical point: High levels of lipoprotein(a) are an independent risk factor for atherosclerotic cardiovascular disease.
Major finding: Serum Lp(a) levels can be used to decide patient risk and treatment options for cardiovascular disease.
Study details: Scientific statement from the National Lipid Association.
Disclosures: Five authors disclosed honorarium or advisory board positions with the pharmaceutical sector. No other conflicts of interest were declared.
Wilson D et al. J Clin Lipidol. 2019 May 17. doi: 10.1016/j.jacl.2019.04.010.